Literature DB >> 2449644

Effect of Abelson murine leukemia virus on granulocytic differentiation and interleukin-3 dependence of a murine progenitor cell line.

G Rovera1, M Valtieri, F Mavilio, E P Reddy.   

Abstract

The murine diploid hematopoietic cell line 32D Cl3 strictly requires interleukin-3 (IL-3) for proliferation. When 32D Cl3 cells are transferred to IL-3-free medium which contains recombinant human granulocyte colony stimulating factor (rhG-CSF), the cell number increases four- to five-fold, and after 14 days the whole cell population is differentiated into morphologically normal and myeloperoxidase- and lactoferrin-positive metamyelocytes and granulocytes. Infection with Abelson murine leukemia virus (A-MuLV) of 32D Cl3 cells growing in the presence of IL-3 induces, within 2 weeks, the appearance of cells that are IL-3-independent for growth. The latter cells lack myeloid, T and B cell markers, and are unable to differentiate, even in the presence of very high doses of rhG-CSF. However, once the 32D Cl3 cells have been exposed to G-CSF, they become resistant to the transforming effects of A-MuLV as judged by the appearance of the IL-3-independent clones. These findings suggest that the ability of Abelson virus to transform immature progenitor cells is due to interference of the v-abl gene product with the mechanisms that control the commitment of the cells to differentiate.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2449644

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

1.  A bcr-v-abl oncogene induces lymphomas in transgenic mice.

Authors:  I K Hariharan; A W Harris; M Crawford; H Abud; E Webb; S Cory; J M Adams
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

2.  Recombinant tumor necrosis factor alpha and interleukin 1 alpha increase expression of c-abl protooncogene mRNA in cultured human marrow stromal cells.

Authors:  D F Andrews; J J Nemunaitis; J W Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

3.  Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein.

Authors:  G Q Daley; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

4.  Hematopoietic cells express two forms of lyn kinase differing by 21 amino acids in the amino terminus.

Authors:  T L Yi; J B Bolen; J N Ihle
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

5.  Abrogation of interleukin-3 dependence of myeloid cells by the v-src oncogene requires SH2 and SH3 domains which specify activation of STATs.

Authors:  P Chaturvedi; S Sharma; E P Reddy
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

6.  Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl.

Authors:  J L Cleveland; M Dean; N Rosenberg; J Y Wang; U R Rapp
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

7.  The promyelocytic leukemia zinc finger protein affects myeloid cell growth, differentiation, and apoptosis.

Authors:  R Shaknovich; P L Yeyati; S Ivins; A Melnick; C Lempert; S Waxman; A Zelent; J D Licht
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

8.  v-myb blocks granulocyte colony-stimulating factor-induced myeloid cell differentiation but not proliferation.

Authors:  G Patel; B Kreider; G Rovera; E P Reddy
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

9.  Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1.

Authors:  J Y Kato; C J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

10.  Wild-type p53 induces diverse effects in 32D cells expressing different oncogenes.

Authors:  S Soddu; G Blandino; R Scardigli; R Martinelli; M G Rizzo; M Crescenzi; A Sacchi
Journal:  Mol Cell Biol       Date:  1996-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.